Takeda Pharmaceutical Company Limited (TAK)

Takeda Pharmaceutical Revenue

Takeda Pharmaceutical had revenue of 1.11T JPY in the quarter ending June 30, 2025, a decrease of -8.39%. This brings the company's revenue in the last twelve months to 4.48T, up 1.52% year-over-year. In the fiscal year ending March 31, 2025, Takeda Pharmaceutical had annual revenue of 4.58T with 7.45% growth.

• Revenue (ttm): 4,480.25B JPY
• Revenue Growth: +1.52%
• P/S Ratio: 1.48
• Revenue / Employee: 94,410,410 JPY
• Employees: 47,455
• Market Cap: 46.04B USD

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	4,581.55B	317.79B	7.45%
Mar 31, 2024	4,263.76B	236.28B	5.87%
Mar 31, 2023	4,027.48B	458.47B	12.85%
Mar 31, 2022	3,569.01B	371.19B	11.61%
Mar 31, 2021	3,197.81B	-93.38B	-2.84%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.